Gamer.Site Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Pharmacy Compounders Defend Semaglutide Compounding Amid...

    www.drugtopics.com/view/pharmacy-compounders-defend-semaglutide-compounding...

    As both the FDA and the Alliance for Pharmacy Compounding (APC) are cautioning patients about buying compounded semaglutide from online pharmacies that are using smeaglutide salts, the APC said that its compounders are allowed to produce legitimate compounded semaglutide 1 —contrary to some state boards of pharmacies, Novo Nordisk, and media reports.

  3. AHA: Semaglutide Significantly Reduces MACE in Adults With...

    www.drugtopics.com/view/aha-semaglutide-significantly-reduces-mace-in-adults...

    Read more: Pharmacy Compounders Defend Semaglutide Compounding Amid Continued Shortages Analyses of the 3 MACE components demonstrated that the risk of nonfatal myocardial infarction was reduced by 28%, cardiovascular death by 15%, and nonfatal stroke by 7% vs placebo (HR, 0.72, 0.85, and 0.93, respectively; the reduction in cardiovascular ...

  4. Breaking: FDA Approves Wegovy to Reduce Cardiovascular Risks in...

    www.drugtopics.com/view/breaking-fda-approves-wegovy-to-reduce-cardiovascular...

    READ MORE: Pharmacy Compounders Defend Semaglutide Compounding Amid Continued Shortages. Serious adverse events occurred in 33.4% and 36.4% of the semaglutide and treatment groups, respectively; 16.6% and 8.2% of those adverse events led to permanent discontinuation of semaglutide or placebo therapy.

  5. Q&A: Understanding the Role of Tirzepatide, Semaglutide in ...

    www.drugtopics.com/view/q-a-understanding-the-role-of-tirzepatide-semaglutide...

    Ambarish Pandey, MD, associate professor of cardiology in internal medicine at the University of Texas Southwestern Medical Center in Dallas, Texas, sat down with Drug Topics ahead of the American Society for Preventive Cardiology Congress on CVD Prevention to discuss recent advancements in the understanding of glucagon-like peptide-1 (GLP-1) therapies’ mechanism of action, clinical ...

  6. Semaglutide Reduces Weight, Truncal Fat In Patients With MASLD

    www.drugtopics.com/view/semaglutide-reduces-weight-truncal-fat-in-patients...

    Semaglutide can help patients with metabolic dysfunction-associated steatotic liver disease (MASLD) lose weight and truncal fat while preserving skeletal muscle over the course of a year, according to research presented at Digestive Disease Week 2024, held May 18 to 21 in Washington, DC. 1. Semaglutide is a glucagon-like peptide-1 (GLP-1 ...

  7. Study Reveals Robust Benefits of Semaglutide in Protecting...

    www.drugtopics.com/view/study-reveals-robust-benefits-of-semaglutide-in...

    Semaglutide may lower the risk of kidney failure and decelerate worsening kidney function, as well as protect against the risk of cardiovascular events and death, among patients with type 2 diabetes (T2D) and chronic kidney disease (CKD), according to results of a new study published in The New England Journal of Medicine. 1

  8. Head to Head Comparison of GLP-1 RAs for Weight Loss Tips Scales...

    www.drugtopics.com/view/head-to-head-comparison-of-glp-1-ras-for-weight-loss...

    Hazard ratios comparing the two medications were 1.76 for 5% or greater weight loss, 2.54 for 10% or greater weight loss, and 3.25 for 15% or greater weight loss. Patients in the tirzepatide group also experienced a higher mean on-treatment change in body weight vs semaglutide: -5.9% vs -3.6% at 3 months, -10.1% vs -5.8% at 6 months, and -15.3% ...

  9. Compounding - drugtopics.com

    www.drugtopics.com/clinical/compounding

    Federal guidance from the United States Pharmacopeia characterizes the practice as drug compounding, which pharmacists fear may drive up prices. Maintaining the structure and function of antibody biologics like faricimab is critical for their administration via intravitreal injection (IVI), a common treatment approach for retinal diseases.

  10. Q&A: Discussing the Dangers of Buying GLP-1s From Online...

    www.drugtopics.com/view/q-a-discussing-the-dangers-of-buying-glp-1s-from...

    Timothy Mackey, MAS, PhD, discusses a study that sought to determine the risk of sourcing semaglutide from online platforms. The rise in popularity of glucagon-like peptide-1 receptor agonists (GLP-1s) since 2022 has resulted in shortages of the drugs and a proliferation of dangerous products being sold through illegal online pharmacies.

  11. Top Takeaways From the Senate Committee Hearing on Semaglutide...

    www.drugtopics.com/view/top-takeaways-from-the-senate-committee-hearing-on...

    Over nearly 2 and a half hours, the committee, chaired by Senator Bernie Sanders (I, Vermont), questioned Jørgensen on topics ranging from the impact of high drug prices to the role of pharmacy benefit managers (PBMs) in the pricing of Novo Nordisk’s blockbuster glucagon-like peptide-1 (GLP-1) receptor agonist semgalutide (Ozempic, Wegovy).